通过小细胞外囊泡介导的脂肪细胞-心肌细胞交叉反应加剧了心力衰竭,保留了喷射分数
Qi Pan1, Cheng Chen1, Ce Zhang1
1Department of Cardiology, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Cardiovascular research
|February 6, 2026
概括
肥胖症通过内脏脂肪组织 (VAT) 信号传递促进心力衰竭与保存的喷射分数 (HFpEF). 携带miR-295-3p的VAT衍生小细胞外囊 (sEV) 破坏心脏自,推动HFpEF的进展.
科学领域:
- 心脏病学 心脏病学
- 代谢疾病 代谢疾病
- 分子生物学分子生物学
背景情况:
- 肥胖和中心脂肪与心力衰竭与保存的喷射分数 (HFpEF) 有关.
- 脂肪和HFpEF病原体之间的因果关系需要进一步澄清.
- 内脏脂肪组织 (VAT) 在新陈代谢调节和心血管健康方面发挥着关键作用.
研究的目的:
- 阐明脂肪在HFpEF病原发生中的因果作用.
- 调查HFpEF中增值税-心脏交叉语音的机制.
- 在HFpEF中确定将增值税与心脏功能障碍联系起来的分子媒介.
主要方法:
- 在使用高脂肪饮食和Nω-nitro-l-arginine甲基的小鼠中诱导HFpEF.
- 进行了内脏脂肪组织切除或移植 (VAT),以评估其对HFpEF表型的影响.
- 分析了VAT分泌的小细胞外囊泡 (sEV),并使用遗传和药理干预研究了它们在HFpEF中的作用.
- 确定了米R-295-3p是sEV中的关键调解物,并研究了它对心脏自的作用.
- 用拉巴胺素和ULK1过度表达来调节心脏自,以评估治疗潜力.
主要成果:
- 增值税操纵显著改变了小鼠中的HFpEF表型.
- 来自HFpEF小鼠的VAT显示体重增加并分泌更多SEVs.
- 抑制sEV分泌或Rab27b敲除,保护免受HFpEF.
- 含有miR-295-3p的增值税衍生sEVs通过准Ulk1的mRNA来损害心脏自.
- MiR-295-3p抑制和恢复心脏自衰减的HFpEF表型.
- 与健康个体相比,HFpEF患者表现出心脏Ulk1和自的减少.
结论:
- 肥胖症通过VAT-心脏交叉声声促进了HFpEF的进展.
- 携带miR-295-3p的增值税衍生sEV会破坏心脏自,从而导致HFpEF的发病.
- 准增值税衍生的sEV和恢复心脏自代表了HFpEF的潜在治疗策略.
相关概念视频
01:29Heart Failure II: Pathophysiology
964
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
964
01:17Pathophysiology of Heart Failure
3.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.8K
01:27Heart Failure I: Introduction
903
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
903
01:22Heart Failure VI: Adjunct Therapies
348
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
348
01:22Heart Failure Drugs: Diuretics
987
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
987
01:30Heart Failure V: Medical Management
330
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
330